G Dölken

Author PubWeight™ 41.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. Biotechniques 1993 2.10
2 Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood 1992 1.81
3 Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. J Virol 1995 1.72
4 Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinoma. Ann Oncol 1991 1.47
5 Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia 2005 1.39
6 Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission. Leukemia 2009 1.08
7 Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hamato-Onkologie OSHO-53 phase II study. Ann Oncol 2006 1.08
8 BCL-2 induction is part of the strategy of Epstein-Barr virus. Leuk Lymphoma 1994 1.00
9 High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's disease. Lancet 1992 0.95
10 Immunofluorescent localization of glycogenolytic and glycolytic enzyme proteins and of malate dehydrogenase isozymes in cross-striated skeletal muscle and heart of the rabbit. Histochemistry 1975 0.94
11 Low frequency of BCL-2/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals. Blood 2001 0.92
12 Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes. Biotechniques 1998 0.89
13 [Malignant melanoma of the anorectal mucosa]. Dtsch Med Wochenschr 2004 0.88
14 Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains. Virology 1976 0.88
15 Turnover of several glycolytic enzymes in rabbit heart, soleus muscle and liver. Hoppe Seylers Z Physiol Chem 1974 0.87
16 The inner boundary membrane of mitochondria. Localization and biochemical characterization, possible functions in biogenesis and metabolism. Hoppe Seylers Z Physiol Chem 1974 0.85
17 Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II study. Ann Oncol 2011 0.85
18 Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia. Int J Cancer 1986 0.84
19 Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab. Ann Hematol 2003 0.84
20 A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatants. J Natl Cancer Inst 1977 0.84
21 Some aspects of regulation of enzyme levels in muscle energy-supplying metabolism. Adv Enzyme Regul 1975 0.84
22 Enzyme-linked immunosorbent assay for IgG antibodies to Epstein-Barr virus-associated early antigens and viral capsid antigen. J Immunol Methods 1984 0.83
23 In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA. Leukemia 1993 0.83
24 Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF alone. Bone Marrow Transplant 2010 0.83
25 Molecular remission of FLT3-ITD(+) positive AML relapse after allo-SCT by acute GVHD in addition to sorafenib. Bone Marrow Transplant 2011 0.82
26 Serum levels of circulating ICAM-1 are increased in Hodgkin's disease. Leukemia 1993 0.82
27 Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia. Ann Hematol 1992 0.81
28 Expression of interleukin 10 in B lymphocytes of different origin. Leukemia 1993 0.81
29 Therapy of invasive aspergillosis with itraconazole: improvement of therapeutic efficacy by early diagnosis. Mycoses 1992 0.81
30 [Neurotoxicity of 5-fluorouracil]. Dtsch Med Wochenschr 2002 0.81
31 Characterization of the Epstein-Barr virus-induced early polypeptide complex p50/58 EA-D using rabbit antisera, a monoclonal antibody, and human antibodies. Virology 1987 0.80
32 Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation. Bone Marrow Transplant 2000 0.80
33 Purification of a protein (60K/58K) associated with the Epstein-Barr virus-induced early antigen complex in Raji cells. Int J Cancer 1983 0.80
34 [Therapy-resistant cutaneous infiltrates in chronic lymphocytic leukemia]. Hautarzt 2006 0.79
35 The significance of serum levels of soluble 60kDa receptors for tumor necrosis factor in patients with Hodgkin's disease. Leukemia 1993 0.79
36 Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J Clin Oncol 1993 0.79
37 Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group. Blood 1998 0.78
38 Disseminated testicular cancer with bulky disease: results of a phase-II study with cisplatin ultra high dose/VP-16/bleomycin. Int J Androl 1987 0.78
39 Turnover of malate-dehydrogenase isozymes in rabbit liver and heart. Eur J Biochem 1974 0.78
40 Fibrinogen gamma-chain mRNA is not detected in human megakaryocytes. Blood 1991 0.77
41 No evidence for HTLV infection among leukaemia patients in Germany. Lancet 1984 0.77
42 Detection of the Epstein-Barr virus-associated antigens EA (early antigen) and VCA (viral capsid antigen) by direct or indirect binding of iodinated antibodies to antigen immobilized in polyacrylamide gel. Eur J Cancer 1979 0.77
43 Translocation t(8;13) in a patient with T cell lymphoma and features of a myeloproliferative syndrome. Leukemia 1995 0.76
44 Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAs. FEBS Lett 1994 0.76
45 High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study. Ann Oncol 1990 0.75
46 Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease. J Clin Oncol 1997 0.75
47 Detection of IgA antibodies to Epstein-Barr virus-associated antigens by ELISA. J Immunol Methods 1984 0.75
48 Purification of a polypeptide complex (p52) belonging to the D-subspecificites of Epstein-Barr virus-induced early antigens. Virology 1986 0.75
49 Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantation. Ann Hematol 1991 0.75
50 Intracerebellar tuberculoma in a patient with AIDS. A case report. Zentralbl Bakteriol 1998 0.75
51 [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]. Dtsch Med Wochenschr 1984 0.75
52 [Not Available]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2002 0.75
53 Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides. Infection 1991 0.75
54 Successful treatment of an HHV6B-induced diarrhea with ganciclovir in a patient after PBSCT. Bone Marrow Transplant 2008 0.75
55 Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial. Oncology 2002 0.75
56 Solid-phase radioimmunoassay for hepatitis Be antigen (HBeAg). Klin Wochenschr 1979 0.75
57 Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia. Leuk Lymphoma 2000 0.75
58 Allogeneic family-unrelated bone marrow transplantation in acute and chronic myeloid leukemia. Bone Marrow Transplant 1993 0.75
59 [Lactate dehydrogenase-isozyme patterns in the myocardium and Purkinje cells of the calf heart (author's transl)]. Z Klin Chem Klin Biochem 1973 0.75
60 Isolation of autologous antibodies to antigens-associated with Hodgkin's disease. Biomedicine 1981 0.75
61 [Thoracic neuroblastoma in a young adult]. Dtsch Med Wochenschr 2004 0.75
62 Facial rash mimicking cutaneous acute graft-versus-host disease after allogeneic stem cell transplantation for osteomyelofibrosis - was Demodex the culprit? Bone Marrow Transplant 2006 0.75
63 [Gastroenterologic findings in graft versus host disease after allogenic bone marrow transplantation]. Z Gastroenterol 1991 0.75
64 Characterization of lymphoid cells by two-dimensional mini gel electrophoresis of proteins. J Cancer Res Clin Oncol 1983 0.75
65 Late extramedullary relapse after allogeneic transplantation in a case of variant hairy cell leukaemia. Bone Marrow Transplant 2009 0.75
66 [Relationships of enzyme-kinetic properties of cardiac LDH-isoenzymes to cell metabolism]. Verh Dtsch Ges Inn Med 1971 0.75
67 Immunoglobulin light chains in chronic lymphocytic leukemia and related diseases. Blut 1984 0.75
68 Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens. Bone Marrow Transplant 2001 0.75
69 Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen. Cancer Detect Prev 1983 0.75
70 [Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group]. Med Klin (Munich) 1992 0.75
71 Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease. Leuk Lymphoma 1994 0.75
72 [Minimal residual disease in follicular and mantle cell lymphoma. Detection using quantitative molecular monitoring of circulating lymphoma cells]. Dtsch Med Wochenschr 2005 0.75
73 Calcium-related changes of enzyme activities in energy metabolism of cultured embryonic chick myoblasts and myotubes. Eur J Biochem 1975 0.75
74 Serum antibodies to a normal cellular protein (P-65) in patients with Hodgkin's disease. J Cancer Res Clin Oncol 1988 0.75
75 Radioimmunoassay for Epstein--Barr virus (EBV)-associated nuclear antigen (EBNA). Binding of iodinated antibodies to antigen immobilized in polyacrylamide gel. Eur J Cancer 1977 0.75
76 [Plasma cell infiltration of the liver in multiple myeloma]. Dtsch Med Wochenschr 2002 0.75
77 Studies on the biosynthesis of malate dehydrogenase isozymes in rabbit liver. Isolation of the in vivo labelled isozymes by specific antibodies. FEBS Lett 1973 0.75
78 Solid-phase radioimmunoassays for Epstein-Barr virus associated antigens. Ric Clin Lab 1982 0.75
79 The modification of high-dose therapy shortens the duration of neutropaenia by delay of leucocyte nadir. Bone Marrow Transplant 2006 0.75
80 [Current status of the therapy of malignant testicular tumors]. Dtsch Med Wochenschr 1988 0.75